References
- Mandelkorn J B, Nelson M W, Surender S, et al. Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol 1983; 52: 1–6
- Epstein E S, Palmeri S T. Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy. Am J Cardiol 1984; 54: 1245–52
- Willerson J T, Campbell W B, Winnieford M D, et al. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. Am J Cardiol 1984; 54: 1349–55
- O'Connor N T, Cederholm-Williams S, Copper S, Cotter L. Hypercoagulability and coronary artery disease. Br Heart J 1984; 52: 614–6
- Baker J A, Eastham R, Elwood P C, Etherington M, O'Brien J R, Sweetnam P M. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J 1982; 47: 490–4
- Yarnell J WG, Sweetnam P M, Elwood P C, et al. Haemostatic factors and ischaemic heart disease. The Caerphilly study. Br Heart J 1985; 53: 483–7
- Cristal N, Slonim A, Bar-Ilan I, Hart A. Plasma fibrinogen levels and the clinical course of acute myocardial infarction. Angiology 1983; 11: 693–98
- Ogston C M, Ogston D. Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Path 1966; 19: 352–6
- Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5
- Meade T W, Chakrabarti R, Haines A P, North W RS, Stirling Y, Thompson S G. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; i: 1050–4
- Stone M C, Thorp J M. Plasma fibrinogen–a major coronary risk factor. Atherosclerosis and cardiovascular diseases, S Lenzi, G C D'esco-Vitch. Editrice Compositori, Bologna 1984; 3–10
- Cristal N, Slonim A, Hagay Z, Silverman C, Ronen M. Plasma fibrinogen levels as an indicator of myocardial necrosis. J Royal Col Phys Lond 1982; 16: 57–9
- Rose G A, Blackburn H. Cardiovascular survey methods, G A Rose, H Blackburn. WHO, Geneva 1968
- Gillman R F, Fortman S P, Prineas R J, Kottke T E. International diagnostic criteria for acute myocardial infarction and stroke. Prog Cardiol 1984; 108: 150–7
- Swahn E, Areskog M, Wallentin L. Early exercise testing after coronary care for suspected unstable coronary artery disease–safety and diagnostic value. Eur Heart J 1986; 7: 594–601
- Devignes P, Bonnet P. Direct determination of plasma fibrinogen levels by heat precipitation. A comparison of the technique thrombin clottable fibrinogen with spectophotometry and radial immunodiffusion. Clin Chem Acta 1981; 110: 9–17
- Whicher J T, Price C P, Spencer K. Immunonephe-lometric and immunoturbidimetric assays for proteins. CRC, Critical Reviews in Clinical laboratory Sciences 1984; 18: 231–60
- Fuchs J, Weinberger I, Rotenberg Z, et al. Plasma viscosity in ischemic heart disease. Am Heart J 1984; 108: 435–9
- Gallino A, Haeberli A, Baur H R, Straub P W. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. Circulation 1985; 72(1)27–30
- Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71(4)699–708
- Davies M J, Thomas A C. Plaque Assuring–the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: 363–73
- Lowe G DO, Drummond M M, Lorimer A R, et al. Relation between extent of coronary artery disease and blood viscosity. Br Med J 1980; 673–4, March 8
- Hamsten A, Wiman B, De Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–63
- Sinzinger H, Schernthaner Kaliman J. Sensitivity of platelets to prostaglandins in coronary heart disease and angina pectoris. Prostaglandins 1981; 22: 773–81
- Mehta J, Mehta P. Platelet function studies in coronary heart disease. IX. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and endoperoxide analog in angina pectoris. Am J Cardiol 1980; 46: 943–7
- Serneri G G, Gensini G F, Abbote R, et al. Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoana-tomy, risk factors and clinical manifestations. Am Heart J 1981; 101: 185–93
- DeWood M, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897–902
- Ambrose J A, Winters S L, Stern A, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Col Cardiol 1985; 5: 609–16
- Meade T W. Thrombosis and ischaemic heart disease. Br Heart J 1985; 53: 473–6